Risks of stroke, its subtypes and atrial fibrillation associated with glucagon-like peptide 1 receptor agonists versus sodium-glucose cotransporter 2 inhibitors: a real-world population-based cohort study in Hong Kong

BACKGROUND: There are limited data on head-to-head comparative risk of stroke between sodium-glucose cotransporter 2 inhibitors (SGLT2i) and glucagon-like peptide-1 receptor agonists (GLP-1RA). We compared risk of stroke with its subtypes and incident atrial fibrillation (AF) between them. METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales: Lui, David Tak Wai, Tang, Eric Ho Man, Wu, Tingting, Au, Ivan Chi Ho, Lee, Chi Ho, Woo, Yu Cho, Tan, Kathryn Choon Beng, Wong, Carlos King Ho
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9960638/
https://www.ncbi.nlm.nih.gov/pubmed/36829226
http://dx.doi.org/10.1186/s12933-023-01772-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9960638/
https://www.ncbi.nlm.nih.gov/pubmed/36829226
http://dx.doi.org/10.1186/s12933-023-01772-0

Ejemplares similares